CoChat

Shortcomings in the Low-Dose (1 μg) ACTH Test for the Diagnosis of ACTH Deficiency States

Streeten, David H. P. · 1999 · The Journal of Clinical Endocrinology & Metabolism
Cited by 39

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

Severe and long-standing hypocortisolism may result from primary or secondary adrenocortical failure to secrete sufficient cortisol to sustain normal health either in the absence or in the presence of stress. In patients with primarily adrenal failure the diagnosis can be made reliably, quickly, and relatively inexpensively by measurement of the serum cortisol response to a single injection (250 μg) of ACTH1–24 (cosyntropin, tetracosatrin, Cortrosyn (Organon, W. Orange, NJ), or Synacthen (Novartis, Basel, Switzerland): all identical products), administered either i.v. or i.m. as an out-patient procedure. This diagnosis can even be made in many patients by measuring plasma concentrations of endogenous adrenocorticotropin (ACTH) and cortisol in a single blood sample (1). There is also no doubt that profound ACTH deficiency that has been present for more than a few weeks will, by causing severe adrenocortical atrophy or impairment of cortisol secretion, almost always result in a subnormal response in serum cortisol concentration to the “short ACTH test” (2). However, it has been recognized for several years that, in some patients who had adrenal insufficiency secondary to hypothalamic or pituitary failure, the normal result of the short ACTH test with 250μ g did not necessarily indicate normal function of the entire hypothalamic-pituitary-adrenal (HPA) system. This evidence and the fact that plasma ACTH levels rose to extremely high levels after 250 mg of ACTH1–24 led to attempts to determine whether the elevation of plasma ACTH to more physiologically increased concentrations by the injection of lower doses of ACTH1–24, might provide a more reliable means of diagnosing moderate or mild forms of corticotropin deficiency. The fact that 1 μg and 250 μg doses of ACTH1–24 resulted in very similar plasma levels of glucocorticoids at 30 min (3) was substantiated in several subsequent measurements, particularly those of Dickstein et al. (4). These clinical investigators found, in six patients who had been on long-term steroid therapy, that serum cortisol concentration rose to 649 (sd 91) nmol/L, similar to the responses of normal subjects (to 707, sd 55, P > 0.3) after the 250 μg dose of ACTH1–24, but rose subnormally after 1 μg of ACTH1–24 in five of the six steroid-treated patients, to 458 (sd 86) compared with 704 (sd 72) nmol/L in normal subjects (P < 0.01). In contrast to these abnormal responses to the 1 μg dose of ACTH1–24, only one of the six steroid-treated patients responded subnormally to the 250 μg dose. These impressive data stimulated several more recent publications by Dickstein’s and other groups (5–8), in which it was reported that some patients with suspected or established ACTH deficiency responded subnormally to the 1 μg dose of ACTH1–24 (in some instances confirming the conclusions from an abnormal insulin tolerance test) but normally to the 250 μg dose. Such results might reasonably have been expected now that it has been shown that, unlike the usual up-regulation of end-organ receptors in response to reduced concentrations of the appropriate agonist, the ACTH receptors on human adrenocortical cells—at least during culture in vitro—are up-regulated when exposed to increasing ACTH concentrations (10) and would be expected therefore, to be down-regulated by the subnormal plasma concentrations of endogenous ACTH in patients with ACTH deficiency. The article in this issue of JCE&M by Abdu et al. (see page 0000) (9) reports another comparison of cortisol responses to the 1 and 250 μg ACTH1–24 tests and to the insulin tolerance test in a series of 64 patients with suspected or proven pituitary diseases of various types. Using 600 nmol/L (22 μg/dL) as the lower limit of the normal serum cortisol response to 1 μg ACTH1–24, the authors found a sensitivity of 100% compared with responses to the insulin tolerance test. Eleven percent of their patients were abnormal by the low dose test without other clinical or biochemical evidence of cortisol deficiency. The low dose test was found to be superior to the 250 μg ACTH test, and the authors concluded that, as a screening procedure, the low dose test was an attractive alternative to the insulin tolerance test that could be reserved for patients in whom careful clinical evaluation failed to dispel reasonable doubts of possible HPA axis impairment. Used in this way, as a screening test for HPA insufficiency and with the recognition that the insulin tolerance test would be required in patients with borderline responses, the low dose test might eventually prove to be a useful diagnostic procedure. Regrettably, the apparently encouraging evidence supporting the usefulness of the low dose ACTH test has not eliminated all uncertainties. At least two problems indicate that the 1-μg ACTH test cannot provide a conclusive means of excluding the presence of mild or incomplete deficiencies in the functional capacity of the HPA axis. The first problem to be addressed is the

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/jcem.84.3.5581

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

See all 39

Metadata

Authors
Streeten, D. H. P.
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
1999-03
Volume
84
Issue
3
Pages
835-837
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W2151717609
Cited by
39
References
6
FWCI
3.83
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Shortcomings in the Low-Dose (1 μg) ACTH Test for the Diagnosis of ACTH Deficiency States. https://app.cochat.ai/papers/10.1210/jcem.84.3.5581
The paper
Streeten, D. H. P. (1999). Shortcomings in the Low-Dose (1 μg) ACTH Test for the Diagnosis of ACTH Deficiency States. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jcem.84.3.5581

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.